LPL Financial
ABEO icon

LPL Financial’s Abeona Therapeutics ABEO Stock Holding History

LPL Financial’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$370K Buy
70,419
+624
+0.9% +$3.87K ﹤0.01% 5352
2026
Q2 		$431K Buy
69,795
+4,647
+7% +$25.5K ﹤0.01% 5147
2026
Q1 		$292K Buy
65,148
+2,275
+4% +$11.4K ﹤0.01% 5203
2025
Q4 		$331K Buy
62,873
+3,165
+5% +$15.9K ﹤0.01% 5067
2025
Q3 		$315K Buy
59,708
+710
+1% +$4.5K ﹤0.01% 5013
2025
Q2 		$335K Buy
58,998
+688
+1% +$3.92K ﹤0.01% 4700
2025
Q1 		$278K Buy
58,310
+7,550
+15% +$41.1K ﹤0.01% 4634
2024
Q4 		$283K Sell
50,760
-900
-2% -$5.54K ﹤0.01% 4578
2024
Q3 		$326K Buy
51,660
+675
+1% +$3.52K ﹤0.01% 4358
2024
Q2 		$216K Buy
50,985
+20,445
+67% +$104K ﹤0.01% 4503
2024
Q1 		$221K Buy
30,540
+1,200
+4% +$7.6K ﹤0.01% 4437
2023
Q4 		$147K Buy
29,340
+4,890
+20% +$21.5K ﹤0.01% 4473
2023
Q3 		$103K Buy
+24,450
New +$92.5K ﹤0.01% 4408

Other funds holding ABEO

ACM
AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Nan Fung Trinity
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Harbor Capital Advisors
Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

LPL Financial's ABEO Position: Q3 2026 in Review

LPL Financial increased its Abeona Therapeutics (ABEO) stake by 0.89% in Q3 2026, buying an estimated $3.87K and bringing the position to 70,419 shares worth $370K. The position accounts for ﹤0.01% of the portfolio, ranked #5352.

LPL Financial first reported a position in ABEO in Q3 2023 and has held it in 13 quarters since. The position peaked at $431K in Q2 2026. 35 funds tracked by Wall St. Rank hold ABEO as of Q3 2026.

  • LPL Financial held 70,419 shares of Abeona Therapeutics worth $370K as of Q3 2026.
  • LPL Financial bought 624 Abeona Therapeutics shares in Q3 2026, an estimated $3.87K.
  • Abeona Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #5352 holding.
  • LPL Financial first reported a position in Abeona Therapeutics in Q3 2023 and has held it in 13 quarters since.
  • LPL Financial's Abeona Therapeutics position peaked at $431K in Q2 2026.
  • 35 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2026.

Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.